Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Operating Expenses came in at $663.4 million in Q2 2026, down 36.25% on a YoY basis from $1.0 billion in Q2 2025, and up 3.67% quarter-over-quarter from $639.9 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Operating Expenses for 5 consecutive years, with $663.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses fell 36.25% year-over-year to $663.4 million; the trailing twelve-month figure through Jun 2026 stood at $2.7 billion (down 26.53% YoY), and the FY2025 full-year result was $3.6 billion, up 25.81% from the prior year.
- Operating Expenses improved to $663.4 million in Q2 2026 per FTRE's latest filing, from $639.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $1.2 billion in Q1 2025 and bottomed at $488.3 million in Q4 2022.
- Historically, Operating Expenses has averaged $733.6 million across 5 years, with a median of $699.5 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses surged 67.46% in 2025, then tumbled 45.37% in 2026.
- Over 5 years, Operating Expenses stood at $488.3 million in 2022, then surged by 50.26% to $733.7 million in 2023, then rose by 2.58% to $752.6 million in 2024, then decreased by 10.43% to $674.1 million in 2025, then declined by 1.59% to $663.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $663.4 million, $639.9 million, and $674.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 637.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 560.51 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 228.90 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 1.93 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 663.40 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 78.70 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 14.36 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 4.98 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 2.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 663.40 Mn |
| Mar 31, 2026 | 639.90 Mn |
| Dec 31, 2025 | 674.10 Mn |
| Sep 30, 2025 | 709.90 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 752.60 Mn |
| Sep 30, 2024 | 692.90 Mn |
| Jun 30, 2024 | 713.30 Mn |
| Mar 31, 2024 | 699.50 Mn |
| Dec 31, 2023 | 733.70 Mn |
| Sep 30, 2023 | 703.50 Mn |
| Jun 30, 2023 | 693.50 Mn |
| Mar 31, 2023 | 679.80 Mn |
| Dec 31, 2022 | 488.30 Mn |
| Sep 30, 2022 | 693.40 Mn |
| Jun 30, 2022 | 721.90 Mn |